Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects

Brigitte A. Brouwer, Bianca T. A. de Greef, Janneke G. J. Hoeijmakers, Margot Geerts, Maarten van Kleef, Ingemar S. J. Merkies, Catharina G. Faber*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Over the last 10 years, the diagnosis small fiber neuropathy (SFN) has gained recognition worldwide. Patients often suffer from severe neuropathic pain that may be difficult to treat. A substantial subset of patients with SFN is aged 65 years or older, and these patients often exhibit comorbidities and usage of multiple drugs, making neuropathic pain treatment more challenging. In this review, we highlight relevant pathophysiological aspects and discuss currently used therapeutic strategies for neuropathic pain. Possible pitfalls in neuropathic pain treatment in the elderly will be underlined.
Original languageEnglish
Pages (from-to)611-621
JournalDrugs & Aging
Volume32
Issue number8
DOIs
Publication statusPublished - Aug 2015

Fingerprint

Dive into the research topics of 'Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects'. Together they form a unique fingerprint.

Cite this